Emma Saffman is an experienced patent agent specializing in intellectual property since 2000. She practices in all areas of the life sciences, chemistry, and medical devices, with a broad range of experience in Canadian, U.S., and foreign patent prosecution, strategic IP portfolio development and management, patentability and freedom-to-operate analysis, opinions, due diligence evaluations, and litigation support.

Emma has particular expertise in pharmaceuticals, biotechnology, bio-organic chemistry, green chemistry, diagnostics, therapeutics, vaccines, nutraceuticals, functional genomics and proteomics, medical devices, and clean technologies. She has represented a comprehensive range of clients from individuals to multinational corporations, including start-ups, early-stage ventures, universities, research organizations, and pharmaceutical companies.

Prior to joining private practice, Emma was Director for Intellectual Property at Neurochem Inc., where she was responsible for managing and maintaining the company's patent and trademark portfolios worldwide.

Emma lectures regularly at the McGill/IPIC "Understanding Patents" Course in Montreal, and is frequently invited to speak at local and international conferences on various Intellectual Property topics. Recently, she was an invited speaker at the annual LifeSciences UK Patent attorney conference (CIPA), and she contributed to a book chapter on patent practice in "Life Sciences Law in Canada" (a Carswell publication).